VIVEX is expanding our Amnion & Wound Care Distribution Network. Interested in becoming a distribution partner? Click here to learn more.
VIABLE BONE SCAFFOLD

VIA Form+™ is the next generation allograft containing key elements ideal for bone formation and offers a variety of potential clinical applications, including the spine, upper extremity, foot and ankle, oral and maxillofacial, and orthopedic oncology. The allograft is packaged in an easy-to-use syringe with minimal preparation time of under 15 minutes.

osteoconductive three-dimensional scaffold
With cortical and cancellous components
Demineralized cortical bone scaffold
Demineralized cortical bone has been identified to have osteoinductive potential1
Viable endogenous bone cells
Support osteogenic healing processes

VIA Form+ provides an osteoconductive bone scaffold composed of mineralized cancellous bone along with demineralized cortical fibers. Bone fibers offer superior osteoconductivity when compared to powder due to the increased ability for cells to migrate along fibers, creating “cellular highways” for bone formation.2 In contrast, particulate-based demineralized bone matrices (DBMs) have gaps between the particles that osteoblasts cannot always bridge across.2 The demineralized cortical fibers are supplemented with cancellous chips to deliver a 100% human-derived product that mimics the particulate structure of native bone.

PRODUCT INFORMATION
Preparation Time
< 15 minutes
DMSO-FREE CRYOPROTECTANT
Yes
STORAGE
At -65°C or colder
Product Composition
Proprietary mixture of mineralized cancellous bone along with demineralized cortical fibers
Final Preparation
Easy-to-use syringe, just thaw and use!
ORDERING INFORMATION
SIZE
CODE
1.0cc
VCAFX-010000
2.5cc
VCAFX-025000
5.0cc
VCAFX-050000
10.0cc
VCAFX-100000
REFERENCES
1 Gruskin, E. et.al., Demineralized bone matrix in bone repair: history and use. Advanced Drug Delivery Reviews, 2012. 64:1063-1077 Biologics
2 Martin GJ Jr, Boden SD, Titus L, Scarborough NL, “New formulations of demineralized bone matrix as a more effective graft alternative in experimental posterolateral lumbar spine arthrodesis.”, Spine. 1999 Apr 1;24(7):637-45.